OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse
Chi Hon Sia, Ziteng Wang, Evelyn Mei Ling Goh, et al.
Clinical Chemistry (2021) Vol. 67, Iss. 11, pp. 1534-1544
Open Access | Times Cited: 23

Showing 23 citing articles:

Elucidating the Phase I metabolism of psilocin in vitro
Junqi Chen, Ziteng Wang, Ching Yee Yong, et al.
Archives of Toxicology (2025)
Closed Access | Times Cited: 1

The metabolism of the synthetic cannabinoids ADB‐BUTINACA and ADB‐4en‐PINACA and their detection in forensic toxicology casework and infused papers seized in prisons
Robert Kronstrand, Caitlyn Norman, Svante Vikingsson, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 4, pp. 634-652
Open Access | Times Cited: 51

Adulteration of low‐delta‐9‐tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services
Manuela Carla Monti, Jill Zeugin, Konrad R. Koch, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 6, pp. 1026-1039
Open Access | Times Cited: 26

ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market
Arianna Giorgetti, Annette Zschiesche, Olwen Groth, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 11, pp. 1350-1365
Open Access | Times Cited: 5

The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC–QTOF-MS and synthesized reference standards
Steven Baginski, Tobias Rautio, Lorna A. Nisbet, et al.
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 9, pp. 826-834
Open Access | Times Cited: 8

Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5‐bromo‐indazole‐3‐carboxamide synthetic cannabinoid receptor agonists
Caitlyn Norman, Kristin Webling, O. А. Kyslychenko, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 9, pp. 915-935
Open Access | Times Cited: 7

Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples
Kunshan Gu, Shiyang Qin, Ying Zhang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 220, pp. 114985-114985
Closed Access | Times Cited: 9

Quantification of MDMB-4en-PINACA and ADB-BUTINACA in human hair by gas chromatography–tandem mass spectrometry
Yue Wang, Yefei Pan, Yang Hongkun, et al.
Forensic Toxicology (2022) Vol. 40, Iss. 2, pp. 340-348
Closed Access | Times Cited: 8

In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH‐PIATA, a new indole‐3‐acetamide synthetic cannabinoid
Caitlyn Norman, Marie H. Deventer, Olivia Dremann, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 4, pp. 380-391
Open Access | Times Cited: 4

Direct and selective alkylation of indazole-3-carboxylic acid for the preparation of synthetic cannabinoids and metabolites
Tobias Rautio, Matthew Connolly, Huiling Liu, et al.
Forensic Chemistry (2024) Vol. 40, pp. 100603-100603
Open Access | Times Cited: 1

Identification of Optimal Urinary Biomarkers of Synthetic Cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for Illicit Abuse Monitoring
Keane Zhi Hao Lee, Ziteng Wang, Ching Yee Fong, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 11, pp. 1436-1448
Open Access | Times Cited: 7

Detection of ADB-4en-PINACA metabolite in the authentic urine samples
Ching Yee Fong, Hooi Yan Moy
Emerging Trends in Drugs Addictions and Health (2024) Vol. 4, pp. 100146-100146
Open Access

Metabolic characteristic profiling of 1-amino-3,3-dimethyl-1-oxobutan-2-yl-derived indole and indazole synthetic cannabinoids in vitro
Xuan Luo, Zihan Huang, Kejian Huang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 250, pp. 116385-116385
Closed Access

Unraveling the liver metabolomic profile of ADB-BUTINACA-induced hepatotoxicity
Yilei Fan, Yingyu Huang, Yi Zhou, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 288, pp. 117375-117375
Open Access

Advances in urinary biomarker research of synthetic cannabinoids
Ziteng Wang, Eric Yu Quan Leow, Hooi Yan Moy, et al.
Advances in clinical chemistry (2023), pp. 1-32
Closed Access | Times Cited: 1

Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol
Ziteng Wang, Ching Yee Fong, Evelyn Mei Ling Goh, et al.
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 9, pp. 1016-1024
Closed Access | Times Cited: 3

New Synthetic Cannabinoid ADB-BUTINACA-Related Death of a Police Dog
Bogdan Tokarczyk, Marta Suchan, Piotr Adamowicz
Journal of Analytical Toxicology (2022) Vol. 47, Iss. 2, pp. e23-e28
Closed Access | Times Cited: 2

Page 1

Scroll to top